- Home
- ATYR vs COOK Comparison
ATYR vs COOK Comparison
Compare ATYR & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- COOK
- Stock Information
- Founded
- ATYR 2005
- COOK 1985
- Country
- ATYR United States
- COOK United States
- Employees
- ATYR N/A
- COOK N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- COOK Wholesale Distributors
- Sector
- ATYR Health Care
- COOK Consumer Discretionary
- Exchange
- ATYR Nasdaq
- COOK Nasdaq
- Market Cap
- ATYR 306.2M
- COOK 255.1M
- IPO Year
- ATYR 2015
- COOK 2021
- Fundamental
- Price
- ATYR $5.22
- COOK $1.81
- Analyst Decision
- ATYR Strong Buy
- COOK Buy
- Analyst Count
- ATYR 6
- COOK 7
- Target Price
- ATYR $20.20
- COOK $2.43
- AVG Volume (30 Days)
- ATYR 2.5M
- COOK 820.9K
- Earning Date
- ATYR 08-12-2025
- COOK 08-05-2025
- Dividend Yield
- ATYR N/A
- COOK N/A
- EPS Growth
- ATYR N/A
- COOK N/A
- EPS
- ATYR N/A
- COOK N/A
- Revenue
- ATYR N/A
- COOK $602,441,000.00
- Revenue This Year
- ATYR $960.85
- COOK $0.06
- Revenue Next Year
- ATYR $1,283.47
- COOK $3.18
- P/E Ratio
- ATYR N/A
- COOK N/A
- Revenue Growth
- ATYR N/A
- COOK 0.80
- 52 Week Low
- ATYR $1.42
- COOK $1.28
- 52 Week High
- ATYR $5.98
- COOK $3.97
- Technical
- Relative Strength Index (RSI)
- ATYR 62.87
- COOK 57.58
- Support Level
- ATYR $5.02
- COOK $1.78
- Resistance Level
- ATYR $5.98
- COOK $2.04
- Average True Range (ATR)
- ATYR 0.45
- COOK 0.18
- MACD
- ATYR -0.04
- COOK 0.04
- Stochastic Oscillator
- ATYR 52.94
- COOK 55.98
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.